Home › Funds › Moore Capital Management › BCLI
Moore Capital Management position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q3 2023)200.00K sh
Reported value held$40.02K
Portfolio Weight0.00%
First reportedQ2 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 200.00K | $412.00K | New |
| Q3 2023 | 200.00K | $40.02K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.